Transcription of Optimizing the Human Whole Exome Sequencing Process
{{id}} {{{paragraph}}}
Example: marketing
Optimizing the Human Whole Exome Sequencing Process
Application NoteAuthorsRaouf Ben Abdelali, Laboratoire CERBA, Saint-Ouen L Aum ne, France J r me Audoux, SeqOne, Montpellier, France Detlef Trost, Laboratoire CERBA, Saint-Ouen L Aum ne, France Anissa Zouaoui, SeqOne, Montpellier, France Aicha Boughalem, Laboratoire CERBA, Saint-Ouen L Aum ne, France Ramdane Mallek, Laboratoire CERBA, Saint-Ouen L Aum ne, FranceAdrien Jeanniard, Agilent Technologies Nicolas Philippe SeqOne, Montpellier, FranceRoubila Meziani, Agilent TechnologiesJean-Marc Costa, Laboratoire CERBA, Saint-Ouen L Aum ne, France SummaryThe Laboratoire Cerba (Cerba) has been working with Agilent and SeqOne to optimize its Whole Exome Sequencing (WES) Process .
and reduced sequencing and interpretation costs. Introduction Whole Exome Sequencing (WES) has become an essential tool for health care providers and clinical research laboratories using Next-Generation Sequencing (NGS). WES is a powerful tool for the identification of genetic variations involved
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: